Literature DB >> 6302844

A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog.

N Horiuchi, M F Holick, J T Potts, M Rosenblatt.   

Abstract

A synthetic analog of bovine parathyroid hormone (bPTH), [tyrosine-34] bPTH-(7-34)NH2, was found to inhibit parathyroid hormone action in vivo. When the analog and parathyroid hormone were infused simultaneously to rats at a molar ratio of 200 to 1, the analog inhibited the excretion of urinary phosphate and adenosine 3',5'-monophosphate. When infused alone at the same dose rate, the analog was devoid of agonist activity. The compound was prepared by following design principles developed for inhibitors of parathyroid hormone, and is believed to be the first antagonist of parathyroid hormone that is effective in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302844     DOI: 10.1126/science.6302844

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Hypercalcaemia.

Authors:  B Keogh
Journal:  Ir J Med Sci       Date:  1988-11       Impact factor: 1.568

3.  Malignant hypercalcaemia.

Authors:  J C Stevenson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

4.  Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist.

Authors:  Ross W Cheloha; Tomoyuki Watanabe; Thomas Dean; Samuel H Gellman; Thomas J Gardella
Journal:  ACS Chem Biol       Date:  2016-08-17       Impact factor: 5.100

5.  Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat.

Authors:  T Massfelder; N Parekh; K Endlich; C Saussine; M Steinhausen; J J Helwig
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.

Authors:  S H Doppelt; R M Neer; S R Nussbaum; P Federico; J T Potts; M Rosenblatt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 7.  Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance.

Authors:  Jean E Rivier; Catherine L Rivier
Journal:  Front Neuroendocrinol       Date:  2013-11-20       Impact factor: 8.606

8.  [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.

Authors:  P J Woll; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.

Authors:  S M D'Souza; K J Ibbotson; G R Mundy
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease.

Authors:  J W Ramsay; W F Hendry
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.